Outcomes4Me Secures $21M in Funding Learn more >>

/ Breast Cancer Resources

Breast Cancer Blog and Resources

Articles

Breast imaging is a complex topic that can be difficult to navigate. We had the...
Safety outcomes with first-line treatment of Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) plus Perjeta (pertuzumab) is comparable...
CDK 4/6 inhibitor side effects, treatment length, and more Dr. Pooja Advani is a breast...
Enhertu (fam-trastuzumab deruxtecan-nxki or T-DXd) has shown promising results in slowing down or stopping the...
The American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30...
A recent study is aiming to understand and classify the HER2 protein levels in breast...
One of the most important first steps after receiving a breast cancer diagnosis is understanding...
Could my cancer still come back? You finish treatment. You count the years. You start...